🇺🇸 FDA

Intelligence Platform

Patents

Browse 635 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9290491

Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9283183

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273008

Dual-acting imidazole antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9271965

Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carb

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260414

Inhibitors of hepatitic C virus

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9249105

Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9249099

Crystalline forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9227933

3-phenoxymethylpyrrolidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9226896

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9221763

Process for preparing biphenyl imidazole compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9216971

Quaternary ammonium compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9216970

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212168

Hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9206172

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9206159

Piperazine-piperidine compounds as hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198899

Dual-acting benzoimidazole antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9199993

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9187423

Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9181206

Dual-acting oxazole antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9161990

Hydrochloride salts of a glycopeptide-cephalosporin antbiotic compond

THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9162982

4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9150500

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9150514

Dual-acting antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9126956

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted